1. Home
  2. ALUR vs BNGO Comparison

ALUR vs BNGO Comparison

Compare ALUR & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • BNGO
  • Stock Information
  • Founded
  • ALUR 2009
  • BNGO 2003
  • Country
  • ALUR United States
  • BNGO United States
  • Employees
  • ALUR N/A
  • BNGO N/A
  • Industry
  • ALUR
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ALUR
  • BNGO Industrials
  • Exchange
  • ALUR Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • ALUR 21.1M
  • BNGO 24.3M
  • IPO Year
  • ALUR N/A
  • BNGO 2018
  • Fundamental
  • Price
  • ALUR $2.40
  • BNGO $3.04
  • Analyst Decision
  • ALUR Strong Buy
  • BNGO Buy
  • Analyst Count
  • ALUR 3
  • BNGO 5
  • Target Price
  • ALUR $22.83
  • BNGO $7.33
  • AVG Volume (30 Days)
  • ALUR 68.8K
  • BNGO 110.7K
  • Earning Date
  • ALUR 08-13-2025
  • BNGO 08-14-2025
  • Dividend Yield
  • ALUR N/A
  • BNGO N/A
  • EPS Growth
  • ALUR N/A
  • BNGO N/A
  • EPS
  • ALUR N/A
  • BNGO N/A
  • Revenue
  • ALUR $28,304,000.00
  • BNGO $27,426,000.00
  • Revenue This Year
  • ALUR N/A
  • BNGO N/A
  • Revenue Next Year
  • ALUR $49.37
  • BNGO $15.54
  • P/E Ratio
  • ALUR N/A
  • BNGO N/A
  • Revenue Growth
  • ALUR N/A
  • BNGO N/A
  • 52 Week Low
  • ALUR $2.15
  • BNGO $2.68
  • 52 Week High
  • ALUR $22.25
  • BNGO $37.09
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 34.20
  • BNGO 42.36
  • Support Level
  • ALUR $2.30
  • BNGO $2.92
  • Resistance Level
  • ALUR $2.69
  • BNGO $3.33
  • Average True Range (ATR)
  • ALUR 0.18
  • BNGO 0.16
  • MACD
  • ALUR -0.06
  • BNGO 0.02
  • Stochastic Oscillator
  • ALUR 14.29
  • BNGO 33.33

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: